A HRCT score to differentiate between structural and interstitial lung disease in children with common variable immunodeficiency (CVID) Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010
Iron deficiency as a novel biomarker of functional impairment in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Physiological basis of respiratory disease Year: 2011
Screening for α1-Pi deficiency in patients with lung diseases Source: Eur Respir J 2002; 20: 319-324 Year: 2002
Prevalence of vitamin D deficiency in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015
Are there differences in response to pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF) and COPD patients? Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases Year: 2017
Association between AGTTGFB1ESR1, and VDR gene variants with idiopathic pulmonary fibrosis (IPF) and pulmonary sarcoidosis (PS) clinical features Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases Year: 2017
Does improvement in health status affect long term mortality in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 248s Year: 2002
Granulomatosis-associated common variable immunodeficiency disorder: a case–control study versus sarcoidosis Source: Eur Respir J 2013; 41: 115-122 Year: 2013
Does health status predict survival in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 203s Year: 2002
The HRCT appearances of granulomatous pulmonary disease in common variable immune deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 489s Year: 2004
Pattern of bronchial colonization and inflammatory response in patients with bronchiectasis and immunoglobulin deficiency (Igdef) Source: Eur Respir J 2001; 18: Suppl. 33, 466s Year: 2001
Worsening of functional limitations and health status in patients with chronic obstructive pulmonary (COPD) as compared to patients with other chronic illnesses in a national sample of US adults Source: Eur Respir J 2005; 26: Suppl. 49, 518s Year: 2005
Is high level of IgE an additional problem in smoking patients with severe and very severe chronic obstructive pulmonary disease (COPD)? Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012
Prevalence of self reported physician diagnosed asthma, chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap syndrome Source: Annual Congress 2012 - Epidemiology of asthma Year: 2012
Urban-rural differences in health status among patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Disease management in specific primary care populations Year: 2011
Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016
Idiopathic pulmonary hemosiderosis in children - clinical profile, evolution and response to treatment in eight cases Source: Eur Respir J 2004; 24: Suppl. 48, 399s Year: 2004
Sarcopenia in idiopathic pulmonary fibrosis (IPF): Prevalence and response to pulmonary rehabilitation (PR) Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020
Alpha1-antytripsin deficiency in portuguese COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres Source: Eur Respir J 2010; 35: 960-968 Year: 2010